Furthermore, in breast, colorectal, and pancreatic cancer, there is a progressive increase in the expression of the COL11A1-matrisome signature during tumor development from normal to adenoma to carcinoma in-situ, and further to invasive carcinoma [44]. The gene discussed is COL11A1; the disease is invasive carcinoma.